ACELYRIN INC (SLRN) Stock Analyst Ratings

USA • Nasdaq • NASDAQ:SLRN • US00445A1007

2.27 USD
+0.04 (+1.79%)
At close: May 20, 2025
2.25 USD
-0.02 (-0.88%)
After Hours: 5/20/2025, 8:00:02 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Buy % Consensus

85

ChartMill assigns a Buy % Consensus number of 85% to SLRN. The Buy consensus is the weighted average rating of the current analysts ratings.

  • Analysts have set a mean price target forecast of 8.16. This target is 259.47% above the current price.
  • SLRN was analyzed by 8 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about SLRN.
  • In the previous month the buy percentage consensus was at a similar level.
  • SLRN was analyzed by 8 analysts. More opinions would make the average more meaningful.

Related screens

Find peers with buy consensus above 85%
SLRN Historical Analyst RatingsSLRN Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 2.278.088.168.168.40 - 255.95% 259.47% 259.47% 270.04%

Related screens

Find peers 30% below price target
SLRN Current Analyst RatingSLRN Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0
Up and Down Grades
Date Firm Action Rating
2025-01-07 Citigroup Maintains Neutral -> Neutral
2025-01-07 HC Wainwright & Co. Maintains Neutral -> Neutral
2024-12-11 Wells Fargo Maintains Overweight -> Overweight
2024-12-11 HC Wainwright & Co. Reiterate Neutral -> Neutral
2024-11-14 HC Wainwright & Co. Maintains Neutral -> Neutral
2024-10-16 Wells Fargo Maintains Overweight -> Overweight
2024-08-19 Morgan Stanley Maintains Equal-Weight -> Equal-Weight
2024-08-15 HC Wainwright & Co. Downgrade Buy -> Neutral
2024-08-14 Piper Sandler Maintains Overweight -> Overweight
2024-07-08 Wells Fargo Upgrade Equal-Weight -> Overweight
2024-05-22 HC Wainwright & Co. Maintains Buy -> Buy
2024-05-15 HC Wainwright & Co. Reiterate Buy -> Buy
2024-05-09 HC Wainwright & Co. Maintains Buy -> Buy
2024-04-01 HC Wainwright & Co. Reiterate Buy -> Buy
2024-03-21 Wells Fargo Maintains Equal-Weight -> Equal-Weight
2024-03-20 HC Wainwright & Co. Reiterate Buy -> Buy
2024-03-12 HC Wainwright & Co. Reiterate Buy -> Buy
2023-12-13 Wells Fargo Initiate Equal-Weight
2023-12-08 Citigroup Initiate Neutral
2023-11-29 Morgan Stanley Maintains Equal-Weight -> Equal-Weight
2023-11-28 Jefferies Maintains Buy -> Buy
2023-11-28 HC Wainwright & Co. Reiterate Buy -> Buy
2023-09-13 Morgan Stanley Downgrade Overweight -> Equal-Weight
2023-09-12 HC Wainwright & Co. Reiterate Buy -> Buy
2023-09-05 Morgan Stanley Maintains Overweight -> Overweight
2023-09-05 HC Wainwright & Co. Initiate Buy
2023-06-21 Morgan Stanley Reiterate Overweight -> Overweight
2023-05-30 TD Cowen Initiate Outperform
2023-05-30 Morgan Stanley Initiate Overweight
2023-05-30 Piper Sandler Initiate Overweight

ACELYRIN INC / SLRN FAQ

What is the average price target for ACELYRIN INC (SLRN) stock?

8 analysts have analysed SLRN and the average price target is 8.16 USD. This implies a price increase of 259.47% is expected in the next year compared to the current price of 2.27.


Can you provide the consensus rating for ACELYRIN INC stock?

The consensus rating for ACELYRIN INC (SLRN) is 85 / 100 . This indicates that analysts generally have a positive outlook on the stock.